Clinical Characteristics and Severity Profile of COVID-19 Patient with Hypertension in Palu, Central Sulawesi

Keywords: Severe acute respiratory syndrome coronavirus 2, Hypertension, COVID-19 Severity, Central Sulawesi


Corona virus infection (COVID-19) is still an unsolved problem in Indonesia until this year. Apart from Java, other islands, including Sulawesi, were also badly affected. The very high mortality rate in Central Sulawesi (3.36%) poses a challenge for health workers; therefore, they should be well informed and with up-to-date information about correct therapeutic decisions. One of the most common comorbidities that often occurs with the severity and mortality of COVID-19 is hypertension. This study aims to determine the clinical characteristics and severity profile and their relationship with the mortality rate of COVID-19 patients with hypertension in Palu, Central Sulawesi. A total of 185 data on COVID-19 patients undergoing treatment at the Palu City Hospital during 2021 and meeting the criteria were recruited as research samples. Patients were divided into two categories, hypertensive (43%) and non-hypertensive (57%). The results showed that the age group, comorbid diabetes mellitus, cardiovascular, blood pressure, and blood glucose levels showed a significant relationship between the two groups (p < 0.05). The median length of stay was 12 days, with conditions leading to discharge (83%) and death (17%); patients who died were hospitalized in moderate and severe clinical conditions. Age group, liver function, and kidney function were positively correlated with severity and mortality. However, hypertension did not show a significant relationship with the severity and mortality of COVID-19 patients.

Author Biography

Amarila Malik, Laboratory of Pharmaceutical Microbiology and Biotechnology, Faculty of Pharmacy, Universitas, Indonesia, Depok 16424, West Java, Indonesi


Beltrán-García, J., Osca-Verdegal, R., Pallardó, F. V., Ferreres, J., Rodríguez, M., Mulet, S., … García-Giménez, J. L. (2020). Sepsis and Coronavirus Disease 2019: Common Features and Anti-Inflammatory Therapeutic Approaches. Critical Care Medicine, 48(12), 1841–1844.
Channappanavar, R., Fett, C., Mack, M., Ten Eyck, P. P., Meyerholz, D. K., & Perlman, S. (2017). Sex-Based Differences in Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Infection. The Journal of Immunology, 198(10), 4046–4053.
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., … Zhang, L. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet, 395(10223), 507–513.
Covid-19 Archives - DINKES PROV SULTENG. (n.d.). Retrieved June 24, 2021, from
Deng, S.-Q., & Peng, H.-J. (2020). Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China. Journal of Clinical Medicine, 9(2), 575.
Fuk-Woo Chan, J., Yuan, S., Kok, K.-H., Kai-Wang To, K., Chu, H., Yang, J., … Yuen, K.-Y. (2020). Articles A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Www.Thelancet.Com, 395, 2020.
Giefing-Kröll, C., Berger, P., Lepperdinger, G., & Grubeck-Loebenstein, B. (2015, June 1). How sex and age affect immune responses, susceptibility to infections, and response to vaccination. Aging Cell, Vol. 14, pp. 309–321.
Health, N. I. of. (2020). Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. Disponible en: In Nih (Vol. 2019).
Hill, M. A., Mantzoros, C., & Sowers, J. R. (2020). Commentary: COVID-19 in patients with diabetes. Metabolism: Clinical and Experimental, 107, 154217.
Karyono, D. R., & Wicaksana, A. L. (2020). Current prevalence, characteristics, and comorbidities of patients with COVID-19 in Indonesia. Journal of Community Empowerment for Health, 3(2), 77.
Liu, Y.-F., Zhang, Z., Pan, X.-L., Xing, G.-L., Zhang, Y., Liu, Z.-S., & Tu, S.-H. (2021). The chronic kidney disease and acute kidney injury involvement in COVID-19 pandemic: A systematic review and meta-analysis. PLOS ONE, 16(1), e0244779.
Moon, A. M., & Barritt, A. S. (2021, June 1). Elevated Liver Enzymes in Patients with COVID-19: Look, but Not Too Hard. Digestive Diseases and Sciences, Vol. 66, pp. 1767–1769.
Niu, S., Tian, S., Lou, J., Kang, X., Zhang, L., Lian, H., & Zhang, J. (2020). Clinical characteristics of older patients infected with COVID-19: A descriptive study.
Park, H.-Y., Lee, J. H., Lim, N.-K., Lim, D. S., Hong, S. O., Park, M.-J., … Jeong, E. K. (2020). Presenting characteristics and clinical outcome of patients with COVID-19 in South Korea: A nationwide retrospective observational study. The Lancet Regional Health - Western Pacific, 5(November), 100061.
Peta Sebaran COVID-19 | (2021). Retrieved March 12, 2021, from
Roncon, L., Zuin, M., Rigatelli, G., & Zuliani, G. (2020). Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome.
Sharma, A., Jaiswal, P., Kerakhan, Y., Saravanan, L., Murtaza, Z., Zergham, A., … Malik, P. (2021). Liver disease and outcomes among COVID-19 hospitalized patients – A systematic review and meta-analysis. Annals of Hepatology, 21.
Shi, Y., Yu, X., Zhao, H., Wang, H., Zhao, R., & Sheng, J. (2020). Host susceptibility to severe COVID-19 and establishment of a host risk score: Findings of 487 cases outside Wuhan. Critical Care, 24(1), 2–5.
Shibata, S., Arima, H., Asayama, K., Hoshide, S., Ichihara, A., & Ishimitsu, T. (2020). Hypertension and related diseases in the era of COVID-19 : a report from the Japanese Society of Hypertension Task Force on COVID-19. Hypertension Research.
Smits, S. L., De Lang, A., Van Den Brand, J. M. A., Leijten, L. M., Van Ijcken, W. F., Eijkemans, M. J. C., … Haagmans, B. L. (2010). Exacerbated innate host response to SARS-CoV in aged non-human primates. PLoS Pathogens, 6(2), e1000756.
Sulteng, D. S. (2019). Dinkes Sulteng 2019. Dinas Kesehatan Sulawesi Tengah, 1–222.
WHO Coronavirus Disease (COVID-19) Dashboard | WHO Coronavirus Disease (COVID-19) Dashboard. (n.d.). Retrieved February 20, 2021, from
Wicaksana, A. L., Hertanti, N. S., Ferdiana, A., & Pramono, R. B. (2020). Diabetes management and specific considerations for patients with diabetes during coronavirus diseases pandemic: A scoping review. Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 14(5), 1109–1120.
Xu, W., Huang, C., Fei, L., Li, Q., & Chen, L. (2021). Dynamic changes in liver function tests and their correlation with illness severity and mortality in patients with COVID-19: A retrospective cohort study. Clinical Interventions in Aging, 16, 675–685.
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., … Cao, B. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet, 395(10229), 1054–1062.
How to Cite
Faustine, I., Malik, A., Andrajati, R., & Wanandi, S. I. (2021). Clinical Characteristics and Severity Profile of COVID-19 Patient with Hypertension in Palu, Central Sulawesi. Indonesian Journal of Pharmacy, 32(4), 563-572.
Research Article